Cassava Sciences Inc vs Energy Fuels Inc Ordinary Shares (Canada) — how do they compare? Cassava Sciences Inc trades at $0.71 (market cap $35.34M), while Energy Fuels Inc Ordinary Shares (Canada) trades at $8.31 (market cap $2.21B). The key difference: Energy Fuels Inc Ordinary Shares (Canada) is far larger — about 62.5× Cassava Sciences Inc's market cap, and Cassava Sciences Inc is more actively traded (251,946 versus 15,605,017). Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 38 Days and Energy Fuels Inc Ordinary Shares (Canada) for 0 Days on average.
| FLNA | UUUU | |
|---|---|---|
Market Cap | $35.34M | $2.21B |
Volume | 251,946 | 15,605,017 |
Sector | Health | Energy |
52-Week High | $4.64 | $27.72 |
52-Week Low | $0.68 | $8.34 |
Typical Hold Time | 38 Days | 0 Days |
Enterprise Value | -$47.34M | $1.95B |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.7434, down 3.39% today, with a bearish technical signal despite oscillator bullishness. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates in recent quarters. Recent FDA approval to lift the clinical hold on simufilam for TSC-related epilepsy is a positive development, with Phase 2a trials expected in early 2027.
Outlook remains speculative given negative cash flows and lack of revenue, but analyst consensus is bullish with 67% buy ratings. Key risks include ongoing operational losses and dependence on clinical trial success. The stock presents high-risk biotech opportunity with potential upside from successful drug development.
Energy Fuels (UUUU) trades at $9.27, down 4.04% amid negative sentiment following a securities fraud investigation announcement. The stock shows weak technical positioning near recent lows with neutral indicators. Fundamentally, the company continues to report significant losses with a -77.3% net income margin despite revenue growth projections, while heavy investment in uranium and rare earth expansion creates substantial cash burn.
While analyst consensus remains bullish with a $21.06 price target representing 127% upside, execution risks are elevated. The securities investigation, persistent losses, and massive capital requirements for growth projects create substantial headwinds. Success depends on the company's ability to fund expansion and achieve profitability in the competitive critical minerals sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Energy Fuels Inc. is a US producer of uranium, vanadium, and rare earth elements. It operates the White Mesa Mill in Utah, the only fully licensed and operating conventional uranium processing facility in the country.
Read more on UUUU →